Transforming growth factor-β (TGF-β) expression in cancers is generally regarded as an important therapeutic target because it plays a key role in regulating the proliferation, differentiation and survival of cancer cells (Ciardiello et al., 2020; Li et al., 2020). This evidence concerns the gene TGFB1 and cancer.